Editorial: Considerations for the upcoming FDA REMS proposal

John F. Peppin, DO, FACP, John J. Coleman, PhD, Kenneth L. Kirsh, PhD
2011 Journal of Opioid Management  
doi:10.5055/jom.2011.0060 fatcat:52e7x6nsvjfn7nnod4l3hct5rq